Table 1.
The summary of sample profiles‡.
| Cancer | Total samples | White | Black | Asian |
|---|---|---|---|---|
| BLCA | 382 (233) | 300 (183) | 22 (13) | 42 (26) |
| GBM | 594 (285) | 505 (256) | 50 (17) | 13 (5) |
| HNSC | 522 (504) | 447 (439) | 45 (36) | 11 (11) |
| KIRC | 533 (417) | 466 (390) | 51 (14) | 8 (7) |
| LUAD | 521 (488) | 391 (385) | 52 (29) | 8 (8) |
| LUSC | 496 (178) | 341 (111) | 31 (9) | 9 (5) |
| BRCA | 1080 (967) | 747 (698) | 172 (116) | 61 (57) |
| OV | 588 (371) | 498 (324) | 34 (17) | 20 (12) |
| UCEC | 538 (248) | 372 (193) | 104 (25) | 20 (13) |
| COAD | 455 (216) | 214 (177) | 54 (19) | 11 (7) |
| THCA | 506 (402) | 329 (263) | 27 (18) | 52 (39) |
| CESC | 305 (198) | 210 (142) | 30 (16) | 19 (19) |
| ESCA | 174 (171) | 110 (109) | 2 (2) | 41 (41) |
| KIRP | 272 (168) | 189 (108) | 60 (43) | 5 (2) |
| LIHC | 363 (197) | 175 (120) | 17 (14) | 159 (54) |
| STAD | 453 (288) | 288 (167) | 12 (4) | 89 (76) |
‡Outside the brackets are the numbers of samples with clinical information only. Inside the brackets are the numbers of samples with both clinical and genomic information. Some samples do not belong to any racial group of White, Black or Asian.